Insider-aligned compounder still undervalued at 22x earnings with 34% annual growth.
Tasmea's insider alignment and compounding growth make it a compelling long-term hold — proforma earnings have compounded 34% annually since 2021, yet the stock trades at only 22x trailing earnings.
Tasmea's proforma earnings have compounded 34% per year since 2021, yet the stock trades at just 22x trailing earnings. Insiders own 60% of shares and have never sold, signaling deep conviction in the long-term thesis.
"Revealing My New Largest Stock Position"